Is SMS-201-995 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use SMS-201-995? Is SMS-201-995 safe for nursing mother and child? Does SMS-201-995 extracts into breast milk? Does SMS-201-995 has any long term or short term side effects on infants? Can SMS-201-995 influence milk supply or can SMS-201-995 decrease milk supply in lactating mothers?
SMS-201-995 lactation summary
- DrLact safety Score for SMS-201-995 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of SMS-201-995 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that SMS-201-995 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of SMS-201-995 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About SMS-201-995 usage in lactation
Synthetic analog drug of somatostatin hormone with a stronger and longer effect. Iit inhibits GH. It has been used as treatment of acromegalia, pancreatitis and esophageal varices.
Answer by DrLact: About SMS-201-995 usage in lactation
The excretion of SMS-201-995 into breastmilk has not been studied. However, because it is poorly absorbed orally and has been safely administered directly to infants by injection, it is unlikely to adversely affect the breastfed infant. One breastfed infant apparently experienced no adverse effects during maternal use of SMS-201-995. Until more data are available, SMS-201-995 should be used in nursing mothers with careful infant monitoring, especially if the infant is under 2 months of age.
SMS-201-995 Side Effects in Breastfeeding
One mother was treated for acromegaly during pregnancy and postpartum with SMS-201-995 (dose not stated). She breastfed (extent not stated) her infant for 4 months with no apparent problems noted in the infant.[1]
Alternate Drugs
Octreotide(Safe)
Dimenhydrinate(Low Risk)
Sodium Picosulfate(Safe)
Sulfasalazine(Safe)
Adalimumab(Safe)
Olsalazine(Safe)
Domperidone(Safe)
Rifaximin(Safe)
Mesalamine(Safe)
Ursodiol(Safe)
Loperamide(Safe)
Sucralfate(Safe)
Rabeprazole(Safe)
Senna(Safe)
Peppermint(Safe)
Pantoprazole(Safe)
Cyclizine(Low Risk)
Lansoprazole(Safe)
Metoclopramide(Safe)
Octreotide(Safe)
Esomeprazole(Safe)
Alosetron(Low Risk)
Magnesium Sulfate(Safe)
Ranitidine(Safe)
Trimethobenzamide(Unsafe)
Magnesium Hydroxide(Safe)
Omeprazole(Safe)
Infliximab(Safe)
Certolizumab Pegol(Safe)
Nizatidine(Safe)
Docusate(Safe)
Famotidine(Safe)
Linaclotide(Safe)
Droperidol(Low Risk)
Cimetidine(Low Risk)
Cascara Sagrada(Low Risk)
Dexlansoprazole(Safe)
Thiethylperazine(Unsafe)
Doxylamine(Unsafe)
Cisapride(Safe)
Prochlorperazine(Unsafe)
Magnesium Oxide(Safe)
Bisacodyl(Safe)
Etanercept(Safe)
Misoprostol(Safe)